Biocon Foundation bags 'IHW Gold Award for Diseases Screening Initiative of the Year' for 2022
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
The award was presented to Biocon Foundation as a mark of recognition of various projects undertaken during the year for reducing the environmental impact on cities
Biocon has reported total income of Rs. 2217.4 crores during the period ended June 30, 2022.
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
This further adds to Biocon’s portfolio of vertically integrated complex drug products
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Subscribe To Our Newsletter & Stay Updated